Internacional: Cinven vende su 14% de participación en Medpace
27/08/2018 Nota de prensa INTERNACIONAL: CINVEN VENDE SU 14% DE PARTICIPACIÓN EN MEDPACE. International private equity firm, Cinven, today announces that it has successfully completed the final sell down of its remaining shares in Nasdaq-listed Medpace (‘the Group´), a leading contract research organisation (´CRO´). Following this transaction, Medpace becomes a fully realised investment for Cinven, generating highly…